1. Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate
   Mattias F. Lindberg et al, 2023, Journal of Medicinal Chemistry CrossRef